Axogen director granted 4,392 RSUs
Levine Alan M reported acquisition or exercise transactions in this Form 4 filing.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
4
Rhea-AI Filing Summary
Levine Alan M reported acquisition or exercise transactions in this Form 4 filing.
Axogen, Inc. director Alan M. Levine received an annual equity award in the form of 4,392 restricted stock units (RSUs). Each RSU represents a contingent right to receive one share of Axogen common stock. The grant is valued at $185,000 as of the grant date.
The RSUs were awarded for service on the Board of Directors and vest on June 24, 2027, the one-year anniversary of the grant date. Following this grant, Levine directly holds 4,392 RSUs linked to Axogen common stock.
Insider Trade Summary
Grant/Award: 4,392 shares
Grant/Award
1 txn
Insider
Levine Alan M
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Restricted Stock Units | 4,392 | $0.00 | $0.00 |
Holdings After Transaction:
Restricted Stock Units — 4,392 contracts (Direct)
Footnotes (2)
- F1. Each restricted stock unit represents a contingent right to receive one share of Axogen, Inc. common stock.
- F2. Annual equity grant for service as Director on the Axogen, Inc. Board of Directors. The number of shares pursuant to the equity grant is based on a $185,000 valuation as of the grant date and vests on June 24, 2027, the one-year anniversary of the grant date.
Key Figures
RSUs granted: 4,392 units
Grant valuation: $185,000
RSUs after transaction: 4,392 units
+2 more
5 metrics
RSUs granted
4,392 units
Annual equity grant for Board service
Grant valuation
$185,000
Valuation as of grant date for equity award
RSUs after transaction
4,392 units
Total restricted stock units held directly after grant
Vesting date
June 24, 2027
One-year anniversary of the grant date
RSU-to-share ratio
1 RSU : 1 share
Each RSU represents one Axogen common share
Key Terms
Restricted Stock Units, equity grant, Board of Directors, grant date, +1 more
5 terms
Restricted Stock Units financial
"Each restricted stock unit represents a contingent right to receive one share of Axogen, Inc. common stock."
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
equity grant financial
"Annual equity grant for service as Director on the Axogen, Inc. Board of Directors."
Board of Directors financial
"Annual equity grant for service as Director on the Axogen, Inc. Board of Directors."
The Board of Directors is a group of people chosen by a company's owners to help make big decisions and oversee how the company is run. They act like a team of advisors or managers, making sure the company stays on track and meets its goals. Their choices can influence the company's success and how it grows.
grant date financial
"The number of shares pursuant to the equity grant is based on a $185,000 valuation as of the grant date"
The grant date is the day a company formally gives an employee or contractor the right to receive stock-based compensation, such as stock options or restricted shares. It matters to investors because it fixes key terms—like the price, the start of the ownership clock, and when the award will affect the company’s financial statements and share count—so it can influence dilution, reported expenses, and potential future selling pressure.
vests financial
"and vests on June 24, 2027, the one-year anniversary of the grant date."
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did Axogen (AXGN) director Alan M. Levine report in this Form 4?
Alan M. Levine reported receiving 4,392 restricted stock units as an equity grant. The award compensates his service on Axogen’s Board of Directors and vests after one year, converting into an equal number of Axogen common shares upon settlement.
How many Axogen (AXGN) restricted stock units did Alan M. Levine receive?
He received 4,392 restricted stock units tied to Axogen common stock. Each unit represents a contingent right to receive one share, giving him potential ownership of 4,392 shares once vesting conditions are satisfied and the units are settled into stock.
What is the reported dollar value of Alan M. Levine’s Axogen (AXGN) RSU grant?
The equity grant is based on a valuation of $185,000 as of the grant date. This valuation determined the number of restricted stock units awarded, resulting in 4,392 RSUs being granted as compensation for his Board service.
When do Alan M. Levine’s Axogen (AXGN) restricted stock units vest?
The restricted stock units vest on June 24, 2027, one year after the grant date. Vesting means the units become earned, after which each RSU is eligible to settle into one share of Axogen common stock, subject to plan terms.
What does each restricted stock unit represent in this Axogen (AXGN) filing?
Each restricted stock unit represents a contingent right to receive one share of Axogen common stock. The units have no purchase price and convert into shares only if vesting conditions are met, aligning director compensation with shareholder interests over time.
AI-generated analysis. How Rhea-AI works. Not financial advice.
